{"id":15244,"date":"2022-01-03T16:40:10","date_gmt":"2022-01-03T13:40:10","guid":{"rendered":"https:\/\/zdmaa.com\/tapur-trial-expands-access-to-more-cancer-patients\/"},"modified":"2022-01-04T19:54:00","modified_gmt":"2022-01-04T16:54:00","slug":"tapur-trial-expands-access-to-more-cancer-patients","status":"publish","type":"post","link":"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/","title":{"rendered":"TAPUR denemesi daha fazla kanser hastas\u0131na eri\u015fimi geni\u015fletiyor"},"content":{"rendered":"

TAPUR denemesi daha fazla kanser hastas\u0131na eri\u015fimi geni\u015fletiyor<\/span><\/span><\/span><\/span><\/p>\n

\n

Ara\u015ft\u0131rmac\u0131lar, ilerlemi\u015f kanserleri olan baz\u0131 hastalar i\u00e7in ila\u00e7lara eri\u015fimi geni\u015fletmeyi ve belirli kanser t\u00fcrleri i\u00e7in hen\u00fcz onaylanmam\u0131\u015f ila\u00e7lara verilen bireysel tepkiler hakk\u0131nda veri toplamay\u0131 ve payla\u015fmay\u0131 ama\u00e7layan yeni bir \u00e7al\u0131\u015fma ba\u015flatt\u0131. <\/span>Hedef Fakt\u00f6r ve Kullan\u0131m Profili Kayd\u0131 (TAPUR) \u00e7al\u0131\u015fmas\u0131, t\u00fcm\u00f6rlerinin di\u011fer kanserler i\u00e7in onaylanm\u0131\u015f ila\u00e7larla tedavi edilebilecek bir mutasyona sahip oldu\u011funu ortaya koyan genetik testlerden ge\u00e7mi\u015f hastalar i\u00e7indir. <\/span>\u00c7al\u0131\u015fma kat\u0131l\u0131mc\u0131lar\u0131, ila\u00e7lar ABD G\u0131da ve \u0130la\u00e7 Dairesi (FDA) taraf\u0131ndan kanser t\u00fcrleri i\u00e7in onaylanmam\u0131\u015f olsa bile bu ila\u00e7lara \u00fccretsiz olarak eri\u015febilecekler. <\/span>Amerikan Klinik Onkoloji Derne\u011fi (ASCO) denemeye \u00f6nc\u00fcl\u00fck ediyor.<\/span><\/span><\/p>\n

gelecek dalgas\u0131<\/span><\/span><\/h2>\n

Amerika Kanser Tedavi Merkezlerinde t\u0131p ve bilim \u015fefi Dr. Murray Markman, \u201cBu, kanser ara\u015ft\u0131rmalar\u0131n\u0131n gelece\u011fi\u201d diyor. <\/span><\/span>\u00ae<\/span><\/span><\/sup> (CTCA). <\/span>“ASCO liderli\u011findeki bu deneme, en iyi tedaviyi belirlemeye yard\u0131mc\u0131 olabilecek tek bir hastan\u0131n kanserinde neler bulabilece\u011fimize odaklan\u0131yor. Tedavileri \u00e7ok say\u0131da hastaya g\u00fcvenmek yerine, her bir hastan\u0131n t\u00fcm\u00f6r\u00fcne bak\u0131yoruz. Bu, yeni paradigma olacak. ilerliyoruz.”<\/span><\/span><\/p>\n

Ama\u00e7, gelecekte daha fazla kanser i\u00e7in daha fazla FDA onayl\u0131 ila\u00e7 tedavisi se\u00e7ene\u011fine yol a\u00e7abilecek \u00e7al\u0131\u015fma hastalar\u0131n\u0131n prognozunu iyile\u015ftirmektir. <\/span>Faz I Ara\u015ft\u0131rma ve Klinik Ara\u015ft\u0131rmalar direkt\u00f6r\u00fc Dr. Glenn Weiss, “TAPUR denemesine kat\u0131larak, ila\u00e7lar\u0131n di\u011fer kanserlerdeki, \u015fu anda onaylanmam\u0131\u015f t\u00fcrlerdeki mutasyonlar\u0131 hedefleyerek ne kadar iyi \u00e7al\u0131\u015ft\u0131\u011f\u0131n\u0131 \u00f6\u011frenmeyi umuyoruz” diyor. <\/span>\u0130kincisi. <\/span>Phoenix B\u00f6lge Hastanesi’nde. <\/span>“\u0130stisnai bir ba\u015far\u0131 g\u00f6r\u00fcrsek, geleneksel klinik deney tasar\u0131mlar\u0131yla potansiyel olarak zaman al\u0131c\u0131 bir yol kullanarak bu ila\u00e7lara onay ve daha geni\u015f eri\u015fim i\u00e7in yeni endikasyonlara yol a\u00e7abilir.”<\/span><\/span><\/p>\n

TAPUR “randomize olmayan” bir \u00e7al\u0131\u015fmad\u0131r, yani her uygun kat\u0131l\u0131mc\u0131, t\u00fcm\u00f6rle uyumlu bir ila\u00e7la tedavi edilecek ve hi\u00e7bir kat\u0131l\u0131mc\u0131 plasebo almayacakt\u0131r. <\/span>\u00c7al\u0131\u015fma, \u00e7o\u011fu klinik ara\u015ft\u0131rmaya g\u00f6re daha geni\u015f kat\u0131l\u0131ma izin verecek \u015fekilde tasarlanm\u0131\u015ft\u0131r, ancak t\u00fcm hastalar, kat\u0131lmak i\u00e7in sa\u011fl\u0131kl\u0131 olup olmad\u0131klar\u0131n\u0131 ve di\u011fer uygunluk kriterlerini kar\u015f\u0131lay\u0131p kar\u015f\u0131lamad\u0131klar\u0131n\u0131 belirlemek i\u00e7in de\u011ferlendirilecektir.<\/span><\/span><\/p>\n

TAPUR’a kimler hak kazan\u0131r?<\/span><\/span><\/h2>\n

Uygun hastalarda ileri kat\u0131 t\u00fcm\u00f6r, multipl miyelom veya Hodgkin olmayan B h\u00fccreli lenfoma olmas\u0131 ve standart tedavilerin bitmesi veya mevcut se\u00e7eneklerinin olmamas\u0131 gerekir. <\/span>Ayr\u0131ca, bu deneme yaln\u0131zca FDA onayl\u0131 endikasyonlar\u0131 d\u0131\u015f\u0131nda kullan\u0131lan tedavileri inceleyece\u011finden, hastalar yaln\u0131zca mutasyonlar\u0131na uyan ila\u00e7lar\u0131n kanser t\u00fcrlerini tedavi etmek i\u00e7in onaylanmamas\u0131 durumunda uygun olabilir. <\/span>\u00d6rne\u011fin, yeti\u015fkin bir hasta “Judy”, genom testiyle tan\u0131mlanan spesifik bir mutasyona sahip akci\u011fer kanserine sahipti ve standart tedavi se\u00e7enekleri yoktu. <\/span>TAPUR \u00e7al\u0131\u015fmas\u0131nda mutasyonunuzu hedef almak i\u00e7in tasarlanm\u0131\u015f bir ila\u00e7 mevcuttur, ancak ila\u00e7 akci\u011fer kanserini de\u011fil, yaln\u0131zca cilt kanserini tedavi etmek i\u00e7in onaylanm\u0131\u015ft\u0131r. <\/span>TAPUR’da bu ilaca eri\u015fiminiz vard\u0131r, ancak ayn\u0131 mutasyona sahip bir melanom hastas\u0131 \u00e7al\u0131\u015fma i\u00e7in uygun olmayacakt\u0131r.<\/span><\/span><\/p>\n

Yedi ila\u00e7 \u015firketi – Bayer, Merck Sharp & Dohme, AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Genentech ve Pfizer – ara\u015ft\u0131rmaya kat\u0131larak toplam 17 ila\u00e7 sunuyor. <\/span>Be\u015f CTCA\u00ae hastanesi de dahil olmak \u00fczere \u00fclke genelindeki hastaneler uygun hastalar\u0131 kaydettiriyor.<\/span><\/span><\/p>\n

Dr. Markman, “Burada sahip oldu\u011fumuz \u015fey sadece bir ila\u00e7 veya molek\u00fcl kusuru de\u011fil” diyor. <\/span>“Bu deneyde yer alan bir\u00e7ok molek\u00fcler anormallik, bir\u00e7ok ila\u00e7, bir\u00e7ok \u015firket var. Bu deney, klinik kanser ara\u015ft\u0131rmalar\u0131n\u0131n t\u00fcm dilini de\u011fi\u015ftiriyor. Onkologlar\u0131n kanseri nas\u0131l tedavi etti\u011fine dair d\u00fc\u015f\u00fcnme s\u00fcre\u00e7lerini de\u011fi\u015ftiriyor.”<\/span><\/span><\/p>\n

TAPUR \u00e7al\u0131\u015fmas\u0131 hakk\u0131nda daha fazla bilgi.<\/span><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TAPUR denemesi daha fazla kanser hastas\u0131na eri\u015fimi geni\u015fletiyor Ara\u015ft\u0131rmac\u0131lar, ilerlemi\u015f kanserleri olan baz\u0131 hastalar i\u00e7in ila\u00e7lara eri\u015fimi geni\u015fletmeyi ve belirli kanser t\u00fcrleri i\u00e7in hen\u00fcz onaylanmam\u0131\u015f ila\u00e7lara verilen bireysel tepkiler hakk\u0131nda veri toplamay\u0131 ve payla\u015fmay\u0131 ama\u00e7layan yeni bir \u00e7al\u0131\u015fma ba\u015flatt\u0131. Hedef Fakt\u00f6r ve Kullan\u0131m Profili Kayd\u0131 (TAPUR) \u00e7al\u0131\u015fmas\u0131, t\u00fcm\u00f6rlerinin di\u011fer kanserler i\u00e7in onaylanm\u0131\u015f ila\u00e7larla tedavi edilebilecek …<\/p>\n","protected":false},"author":1,"featured_media":15056,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-15244","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-tr"],"yoast_head":"\nTAPUR denemesi daha fazla kanser hastas\u0131na eri\u015fimi geni\u015fletiyor - zdmaa<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TAPUR denemesi daha fazla kanser hastas\u0131na eri\u015fimi geni\u015fletiyor - zdmaa\" \/>\n<meta property=\"og:description\" content=\"TAPUR denemesi daha fazla kanser hastas\u0131na eri\u015fimi geni\u015fletiyor Ara\u015ft\u0131rmac\u0131lar, ilerlemi\u015f kanserleri olan baz\u0131 hastalar i\u00e7in ila\u00e7lara eri\u015fimi geni\u015fletmeyi ve belirli kanser t\u00fcrleri i\u00e7in hen\u00fcz onaylanmam\u0131\u015f ila\u00e7lara verilen bireysel tepkiler hakk\u0131nda veri toplamay\u0131 ve payla\u015fmay\u0131 ama\u00e7layan yeni bir \u00e7al\u0131\u015fma ba\u015flatt\u0131. Hedef Fakt\u00f6r ve Kullan\u0131m Profili Kayd\u0131 (TAPUR) \u00e7al\u0131\u015fmas\u0131, t\u00fcm\u00f6rlerinin di\u011fer kanserler i\u00e7in onaylanm\u0131\u015f ila\u00e7larla tedavi edilebilecek …\" \/>\n<meta property=\"og:url\" content=\"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"zdmaa\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-03T13:40:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-04T16:54:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/hospital-g930b851a2_640.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"427\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/\",\"url\":\"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/\",\"name\":\"TAPUR denemesi daha fazla kanser hastas\u0131na eri\u015fimi geni\u015fletiyor - zdmaa\",\"isPartOf\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/hospital-g930b851a2_640.webp\",\"datePublished\":\"2022-01-03T13:40:10+00:00\",\"dateModified\":\"2022-01-04T16:54:00+00:00\",\"author\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3\"},\"breadcrumb\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/#primaryimage\",\"url\":\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/hospital-g930b851a2_640.webp\",\"contentUrl\":\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/hospital-g930b851a2_640.webp\",\"width\":640,\"height\":427,\"caption\":\"TAPUR Trial Expands Access to More Cancer Patients\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\",\"item\":\"https:\/\/zdmaa.com\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TAPUR denemesi daha fazla kanser hastas\u0131na eri\u015fimi geni\u015fletiyor\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#website\",\"url\":\"https:\/\/zdmaa.com\/tr\/ro\/\",\"name\":\"zdmaa\",\"description\":\"zdmaa\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/zdmaa.com\/tr\/ro\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1777164375\",\"contentUrl\":\"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1777164375\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/zdmaa.com\"],\"url\":\"https:\/\/zdmaa.com\/tr\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TAPUR denemesi daha fazla kanser hastas\u0131na eri\u015fimi geni\u015fletiyor - zdmaa","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/","og_locale":"tr_TR","og_type":"article","og_title":"TAPUR denemesi daha fazla kanser hastas\u0131na eri\u015fimi geni\u015fletiyor - zdmaa","og_description":"TAPUR denemesi daha fazla kanser hastas\u0131na eri\u015fimi geni\u015fletiyor Ara\u015ft\u0131rmac\u0131lar, ilerlemi\u015f kanserleri olan baz\u0131 hastalar i\u00e7in ila\u00e7lara eri\u015fimi geni\u015fletmeyi ve belirli kanser t\u00fcrleri i\u00e7in hen\u00fcz onaylanmam\u0131\u015f ila\u00e7lara verilen bireysel tepkiler hakk\u0131nda veri toplamay\u0131 ve payla\u015fmay\u0131 ama\u00e7layan yeni bir \u00e7al\u0131\u015fma ba\u015flatt\u0131. Hedef Fakt\u00f6r ve Kullan\u0131m Profili Kayd\u0131 (TAPUR) \u00e7al\u0131\u015fmas\u0131, t\u00fcm\u00f6rlerinin di\u011fer kanserler i\u00e7in onaylanm\u0131\u015f ila\u00e7larla tedavi edilebilecek …","og_url":"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/","og_site_name":"zdmaa","article_published_time":"2022-01-03T13:40:10+00:00","article_modified_time":"2022-01-04T16:54:00+00:00","og_image":[{"width":640,"height":427,"url":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/hospital-g930b851a2_640.webp","type":"image\/webp"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"admin","Tahmini okuma s\u00fcresi":"3 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/","url":"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/","name":"TAPUR denemesi daha fazla kanser hastas\u0131na eri\u015fimi geni\u015fletiyor - zdmaa","isPartOf":{"@id":"https:\/\/zdmaa.com\/tr\/ro\/#website"},"primaryImageOfPage":{"@id":"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/#primaryimage"},"image":{"@id":"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/hospital-g930b851a2_640.webp","datePublished":"2022-01-03T13:40:10+00:00","dateModified":"2022-01-04T16:54:00+00:00","author":{"@id":"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3"},"breadcrumb":{"@id":"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/#primaryimage","url":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/hospital-g930b851a2_640.webp","contentUrl":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/hospital-g930b851a2_640.webp","width":640,"height":427,"caption":"TAPUR Trial Expands Access to More Cancer Patients"},{"@type":"BreadcrumbList","@id":"https:\/\/zdmaa.com\/tr\/tapur-trial-expands-access-to-more-cancer-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629","item":"https:\/\/zdmaa.com\/tr\/"},{"@type":"ListItem","position":2,"name":"TAPUR denemesi daha fazla kanser hastas\u0131na eri\u015fimi geni\u015fletiyor"}]},{"@type":"WebSite","@id":"https:\/\/zdmaa.com\/tr\/ro\/#website","url":"https:\/\/zdmaa.com\/tr\/ro\/","name":"zdmaa","description":"zdmaa","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/zdmaa.com\/tr\/ro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3","name":"admin","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/image\/","url":"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1777164375","contentUrl":"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1777164375","caption":"admin"},"sameAs":["https:\/\/zdmaa.com"],"url":"https:\/\/zdmaa.com\/tr\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts\/15244","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/comments?post=15244"}],"version-history":[{"count":2,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts\/15244\/revisions"}],"predecessor-version":[{"id":15982,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts\/15244\/revisions\/15982"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/media\/15056"}],"wp:attachment":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/media?parent=15244"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/categories?post=15244"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/tags?post=15244"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}